Fig. 8: Mechanism summary diagram.

When MTCH2 expression is defective (MTCH2 knockdown), the amount of NRF2 entering the nucleus is reduced, leading to decreased RRM1 transcription. Consequently, the sensitivity of melanoma cells to Dacarbazine is enhanced, effectively inhibiting their proliferation.